Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate In Men With Metabolic Syndrome

Trial Profile

Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate In Men With Metabolic Syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2011

At a glance

  • Drugs Atorvastatin; Fenofibrate
  • Indications Metabolic syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 16 Nov 2011 Results assessing the effects of treatment on very low density lipoprotein apolipoprotein A catabolism presented at the 84th Annual Scientific Sessions of the American Heart Association.
    • 03 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top